Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Transplantation and Cellular Therapy|May 2, 2024
Chimeric Antigen Receptor T-Cell Access in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Association of Access with Social Determinants of Health and Travel Time to Treatment CentersNausheen Ahmed, Fang Sun, Christie Teigland, et al.
Advances in Therapy|June 21, 2022
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United StatesBijal D Shah, Nathaniel J Smith, Chaoling Feng, et al.
Advances in Therapy|October 6, 2023
Matching-Adjusted Indirect Comparisons of Brexucabtagene Autoleucel with Alternative Standard Therapies for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Adult PatientsBijal Shah, Jenny M H Chen, James J Wu, et al.
Clinical Orthopaedics and Related Research|October 5, 2016
Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model ApproachLane Koenig, Qian Zhang, Matthew S Austin, et al.
Advances in Therapy|March 18, 2024
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase InhibitorGilles Salles, Jenny M H Chen, Ina Zhang, et al.
Lancet (London, England)|June 7, 2021
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 studyBijal D Shah, Armin Ghobadi, Olalekan O Oluwole, et al.
Pageof 2